| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,511 |
5,151 |
$499K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,068 |
1,038 |
$140K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,440 |
1,417 |
$73K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
529 |
497 |
$59K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
530 |
503 |
$57K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
467 |
461 |
$57K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
833 |
785 |
$47K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
274 |
269 |
$37K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,045 |
1,008 |
$21K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,665 |
1,534 |
$19K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
129 |
128 |
$16K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
629 |
603 |
$16K |
| 92551 |
|
1,144 |
1,107 |
$12K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
105 |
104 |
$10K |
| 96127 |
|
855 |
562 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
299 |
282 |
$5K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
31 |
31 |
$3K |
| 99072 |
|
637 |
629 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
75 |
64 |
$2K |
| 99172 |
|
113 |
110 |
$1K |
| 80061 |
Lipid panel |
89 |
86 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
24 |
23 |
$1K |
| 90473 |
|
52 |
52 |
$1K |
| 83655 |
|
27 |
27 |
$403.65 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
24 |
12 |
$385.44 |
| 85018 |
|
149 |
144 |
$384.31 |
| 90686 |
|
1,041 |
1,028 |
$184.69 |
| 90474 |
|
12 |
12 |
$168.96 |
| 90656 |
|
26 |
26 |
$18.98 |
| 91307 |
|
18 |
18 |
$0.18 |
| 91300 |
|
14 |
14 |
$0.14 |
| 99177 |
|
860 |
843 |
$0.00 |
| 90670 |
|
263 |
261 |
$0.00 |
| 90715 |
|
30 |
28 |
$0.00 |
| 90633 |
|
53 |
53 |
$0.00 |
| 90734 |
|
63 |
61 |
$0.00 |
| 90647 |
|
129 |
128 |
$0.00 |
| 90651 |
|
153 |
150 |
$0.00 |
| 90680 |
|
89 |
89 |
$0.00 |
| 90723 |
|
123 |
123 |
$0.00 |
| 90677 |
|
13 |
13 |
$0.00 |